Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
|Articles|October 22, 2011
Gateway 2011: Grand River Aseptic Manufacturing
Advertisement
- General Company Company Description:
Grand River Aseptic Manufacturing is a parenteral contract manufacturer supporting new product development and small batch production. With a state‐of‐the‐art cleanroom and highly trained staff, Grand River Aseptic Manufacturing provides small scale clinical trial materials aseptically filled into vials and lyophilization for the pharmaceutical and biopharmaceutical markets.
Grand River specializes in pre‐clinical, phase I through III clinical trials, and small scale commercial production quantities. We offer the following services for clinical, small scale, and commercial‐stage products: Sterile product development and manufacture, Lyophilization, Terminal sterilization and Analytical and microbiological services.
- Technical Services:
- Sterile product development and manufacture
- Lyophilization of vials 2 to 50 mL
- Terminal sterilization
- Analytical and microbiological services
- Aseptic filling of vials 2 to 50 mL
- Formulation development
- Test method development and validation
- Process development and validation
- Controlled temperature storage
- On-site warehouse and material storage
- Regulatory support
- Facilities:
Our Grand Rapids, Michigan facility includes:
- 11,400-ft2 cGMP FDA registered facility
- Class 100 aseptic filling suite
- Class 10,000 processing area
- Formulation Suite
- Preparation Lab
- Steam Sterilizer
- USP Compliant WFI System
- IMA Edwards Lyophilizer with CIP capabilities (31 ft2)
- Capmatic Bambino Filler and Capper
- PennTech - RW-500 Vial Washer
- Lytzen Depyrogenation Oven
- Major Products/Services:
Grand River specializes in pre‐clinical, phase I through III clinical trials, and small scale commercial production quantities. We offer the following services for clinical, small scale, and commercial‐stage products: Sterile product development and manufacture, Lyophilization, Terminal sterilization and Analytical and microbiological services.
- Markets Served:
Grand River Aseptic Manufacturing serves the global pharmaceutical and biopharmaceutical industries.
Visit us at: Booth 1342
If you would like to schedule a personal meeting during the 2011 AAPS show please call or email: Greg Gonzales at (240) 344-9412 /
Advertisement
Related to this article
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Advertisement
Advertisement